SMAD4 genetic alterations predict a worse prognosis in patients with pancreatic ductal adenocarcinoma

Pancreas

Volumn 41, Issue 4, 2012, Pages 541-546

  Singh, Puneet ^a   Srinivasan, Radhika ^a   Wig, Jai Dev ^a  

^a POSTGRADUATE INSTITUTE OF MEDICAL EDUCATION AND RESEARCH   (India)

Author keywords

genetic alterations; mutation cluster region; pancreatic ductal carcinoma; prognosis; SMAD4

Indexed keywords

SMAD4 PROTEIN;

ADULT; AGED; AMINO TERMINAL SEQUENCE; ARTICLE; CANCER PROGNOSIS; CANCER SURVIVAL; CARBOXY TERMINAL SEQUENCE; CLINICAL ARTICLE; CONTROLLED STUDY; CORRELATION ANALYSIS; DNA POLYMORPHISM; FEMALE; GENE DELETION; GENE INACTIVATION; GENE MUTATION; GENETIC ANALYSIS; GENETIC SCREENING; HOMOZYGOSITY; HUMAN; HUMAN TISSUE; MALE; PANCREAS ADENOCARCINOMA; POLYMERASE CHAIN REACTION; POPULATION GENETICS; PRIORITY JOURNAL; PROTEIN EXPRESSION; RESTRICTION FRAGMENT LENGTH POLYMORPHISM;

ADULT; AGED; CARCINOMA, PANCREATIC DUCTAL; FEMALE; GENETIC MARKERS; HUMANS; INDIA; KAPLAN-MEIER ESTIMATE; MALE; MIDDLE AGED; MUTATION; PANCREATIC NEOPLASMS; POLYMERASE CHAIN REACTION; POLYMORPHISM, SINGLE-STRANDED CONFORMATIONAL; PROPORTIONAL HAZARDS MODELS; PROSPECTIVE STUDIES; SEQUENCE ANALYSIS, DNA; SMAD4 PROTEIN; TUMOR MARKERS, BIOLOGICAL;

EID: 84859941196     PISSN: 08853177     EISSN: 15364828     Source Type: Journal    
DOI: 10.1097/MPA.0b013e318247d6af     Document Type: Article

References (18)

1. Tascilar M, Offerhaus GJ, Altink R, et al. Immunohistochemical labeling for the Dpc4 gene product is a specific marker for adenocarcinoma in biopsy specimens of the pancreas and bile duct. Am J Clin Pathol. 2001;116(6):831-837. (Pubitemid 33108153)
2. Hua Z, Zhang YC, Hu XM, et al. Loss of DPC4 expression and its correlation with clinicopathological parameters in pancreatic carcinoma. World J Gastroenterol. 2003;9(12):2764-2767. (Pubitemid 38054456)
3. Hruban RH, Offerhaus GJ, Kern SE, et al. Tumor-suppressor genes in pancreatic cancer. J Hepatobiliary Pancreat Surg. 1998;5(4):383-391. (Pubitemid 128662609)
4. Houlston R, Bevan S, Williams A, et al. Mutations in DPC4 (SMAD4) cause juvenile polyposis syndrome, but only account for a minority of cases. Hum Mol Genet. 1998;7(12):1907-1912. (Pubitemid 28499422)
5. Hayashi K. PCR-SSCP: a simple and sensitive method for detection of mutations in the genomic DNA. PCR Methods Appl. 1991;1(1):34-38.
6. Bassam BJ, Caetano-Anolles G, Gresshoff PM. Fast and sensitive silver staining of DNA in polyacrylamide gels. Anal Biochem. 1991;196(1):80-83.
7. Sobin LH, Fleming ID. TNM classification of malignant tumors, fifth edition (1997). Union Internationale Contre le Cancer and the American Joint Committee on Cancer. Cancer. 1997;80(9):1803-1804.
8. Hahn SA, Schutte M, Hoque AT, et al. DPC4, a candidate tumor suppressor gene at human chromosome 18q21.1. Science. 1996;271(5247):350-353.
9. Jonson T, Gorunova L, Dawiskiba S, et al. Molecular analyses of the 15q and 18q SMAD genes in pancreatic cancer. Genes Chromosomes Cancer. 1999;24(1):62-71. (Pubitemid 28544464)
10. Moore PS, Orlandini S, Zamboni G, et al. Pancreatic tumours: molecular pathways implicated in ductal cancer are involved in ampullary but not in exocrine nonductal or endocrine tumorigenesis. Br J Cancer. 2001;84(2):253-262. (Pubitemid 32113454)
11. Gerdes B, Wild A, Wittenberg J, et al. Tumor-suppressing pathways in cystic pancreatic tumors. Pancreas. 2003;26(1):42-48. (Pubitemid 36020265)
12. Iacobuzio-Donahue CA, Song J, Parmiagiani G, et al. Missense mutations of MADH4: characterization of the mutational hot spot and functional consequences in human tumors. Clin Cancer Res. 2004;10(5):1597-1604. (Pubitemid 38435548)
13. van Heek T, Rader AE, Offerhaus GJ, et al. K-ras, p53, and DPC4 (MAD4) alterations in fine-needle aspirates of the pancreas: a molecular panel correlates with and supplements cytologic diagnosis. Am J Clin Pathol. 2002;117(5):755-765. (Pubitemid 34457011)
14. Wang LH, Kim SH, Lee JH, et al. Inactivation of SMAD4 tumor suppressor gene during gastric carcinoma progression. Clin Cancer Res. 2007;13(1):102-110. (Pubitemid 46121858)
15. Biankin AV, Morey AL, Lee CS, et al. DPC4/Smad4 expression and outcome in pancreatic ductal adenocarcinoma. J Clin Oncol. 2002;20(23):4531-4542. (Pubitemid 35402956)
16. Blackford A, Serrano OK, Wolfgang CL, et al. SMAD4 gene mutations are associated with poor prognosis in pancreatic cancer. Clin Cancer Res. 2009;15(14):4674-4679.
17. Kuang C, Chen Y. Tumor-derived C-terminal mutations of Smad4 with decreased DNA binding activity and enhanced intramolecular interaction. Oncogene. 2004;23(5):1021-1029. (Pubitemid 38269956)
18. Xu J, Attisano L. Mutations in the tumor suppressors Smad2 and Smad4 inactivate transforming growth factor beta signaling by targeting Smads to the ubiquitin-proteasome pathway. Proc Natl Acad Sci U S A. 2000;97(9):4820-4825. (Pubitemid 30238641)